Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimization of intradermal vaccination by DNA tattooing in human skin.
van den Berg JH, Nujien B, Beijnen JH, Vincent A, van Tinteren H, Kluge J, Woerdeman LA, Hennink WE, Storm G, Schumacher TN, Haanen JB. van den Berg JH, et al. Among authors: van tinteren h. Hum Gene Ther. 2009 Mar;20(3):181-9. doi: 10.1089/hum.2008.073. Hum Gene Ther. 2009. PMID: 19301471 Free PMC article.
Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands.
Kruijtzer CMF, Verweij J, Schellens JH, Beijnen JH, Pronk L, Bo M, Lustig V, van Tinteren H, Mackay M, Ten Bokkel Huinink WW. Kruijtzer CMF, et al. Among authors: van tinteren h. Anticancer Drugs. 2000 Apr;11(4):249-55. doi: 10.1097/00001813-200004000-00004. Anticancer Drugs. 2000. PMID: 10898539 Clinical Trial.
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer.
Kruijtzer CM, Boot H, Beijnen JH, Lochs HL, Parnis FX, Planting AS, Pelgrims JM, Williams R, Mathôt RA, Rosing H, Schot ME, Van Tinteren H, Schellens JH. Kruijtzer CM, et al. Among authors: van tinteren h. Ann Oncol. 2003 Feb;14(2):197-204. doi: 10.1093/annonc/mdg078. Ann Oncol. 2003. PMID: 12562644 Free article. Clinical Trial.
TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.
de Witte MA, Bendle GM, van den Boom MD, Coccoris M, Schell TD, Tevethia SS, van Tinteren H, Mesman EM, Song JY, Schumacher TN. de Witte MA, et al. Among authors: van den boom md, van tinteren h. J Immunol. 2008 Aug 15;181(4):2563-71. doi: 10.4049/jimmunol.181.4.2563. J Immunol. 2008. PMID: 18684947 Free PMC article.
Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.
Gast MC, van Tinteren H, Bontenbal M, van Hoesel RQ, Nooij MA, Rodenhuis S, Span PN, Tjan-Heijnen VC, de Vries EG, Harris N, Twisk JW, Schellens JH, Beijnen JH. Gast MC, et al. Among authors: van hoesel rq, van tinteren h. BMC Cancer. 2008 Dec 24;8:389. doi: 10.1186/1471-2407-8-389. BMC Cancer. 2008. PMID: 19108738 Free PMC article. Clinical Trial.
Survival after cystectomy for invasive bladder cancer.
de Vries RR, Nieuwenhuijzen JA, Vincent A, van Tinteren H, Horenblas S. de Vries RR, et al. Among authors: van tinteren h. Eur J Surg Oncol. 2010 Mar;36(3):292-7. doi: 10.1016/j.ejso.2009.11.012. Epub 2010 Jan 25. Eur J Surg Oncol. 2010. PMID: 20097512
324 results